Elizabeth A. Clutterbuck

Old Road, Headington
Oxford, ENG OX37LE, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.

ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.

Journal: Vaccine

Published: March 19, 2026

MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines.

MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines.

Journal: Science immunology

Published: August 29, 2025

Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trial.

Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trial.

Journal: The Journal of infection

Published: May 27, 2025

Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial.

Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial.

Journal: EBioMedicine

Published: March 25, 2025

Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study.

Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study.

Journal: The Journal of infection

Published: January 11, 2025

Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine.

Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine.

Journal: Nature communications

Published: June 19, 2024

A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens.

A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens.

Journal: Journal of immunological methods

Published: May 21, 2024

The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.

The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.

Journal: The Pediatric infectious disease journal

Published: May 08, 2024

Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination.

Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination.

Journal: Frontiers in immunology

Published: February 08, 2024

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.

Journal: Science translational medicine

Published: June 21, 2023

Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.

Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.

Journal: The Journal of infection

Published: May 22, 2023

Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children.

Memory-like innate response to booster vaccination with MF-59 adjuvanted influenza vaccine in children.

Journal: NPJ vaccines

Published: February 27, 2023

Showing 1-12 of 69

Last Updated: 09/26/2026